Product
ABBV-903
Aliases
Placebo for ABBV-903
6 clinical trials
2 indications
Indication
Healthy VolunteerIndication
Healthy Control ParticipantsClinical trial
Mass Balance Study of [14C] ABBV-903 in Healthy Male Subjects Following Single Oral Dose AdministrationStatus: Completed, Estimated PCD: 2023-10-13
Clinical trial
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese SubjectsStatus: Terminated, Estimated PCD: 2023-10-30
Clinical trial
Assessment of the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2023-12-10
Clinical trial
A Phase 1 Open-Label Drug-Drug Interaction Study Between ABBV-903 and MidazolamStatus: Completed, Estimated PCD: 2023-11-02
Clinical trial
Assessment of the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-06-20
Clinical trial
A Phase 1 First in Human, Single and Multiple Ascending Dose and Food Effect and Drug-Drug Interaction in Healthy Subjects to Evaluate the Safety, Tolerability and Assessment of Pharmacokinetics of ABBV-903Status: Completed, Estimated PCD: 2023-10-23